Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q34146766)
Watch
English
The rise and fall of Dimebon
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
21031168
retrieved
31 July 2017
title
The rise and fall of Dimebon
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
21031168
retrieved
31 July 2017
author name string
Ilya Bezprozvanny
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
21031168
retrieved
31 July 2017
publication date
1 October 2010
1 reference
stated in
Europe PubMed Central
PubMed ID
21031168
retrieved
31 July 2017
published in
Drug News and Perspectives
1 reference
stated in
Europe PubMed Central
PubMed ID
21031168
retrieved
31 July 2017
volume
23
1 reference
stated in
Europe PubMed Central
PubMed ID
21031168
retrieved
31 July 2017
page(s)
518-523
1 reference
stated in
Europe PubMed Central
PubMed ID
21031168
retrieved
31 July 2017
issue
8
1 reference
stated in
Europe PubMed Central
PubMed ID
21031168
retrieved
31 July 2017
cites work
A randomized, placebo-controlled trial of latrepirdine in Huntington disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922928
retrieved
5 July 2018
Acute dosing of latrepirdine (Dimebon), a possible Alzheimer therapeutic, elevates extracellular amyloid-beta levels in vitro and in vivo
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922928
retrieved
5 July 2018
From anti-allergic to anti-Alzheimer's: Molecular pharmacology of Dimebon.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922928
retrieved
5 July 2018
Dimebon as a potential therapy for Alzheimer's disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922928
retrieved
5 July 2018
Methylene blue and dimebon inhibit aggregation of TDP-43 in cellular models.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922928
retrieved
5 July 2018
Dimebolin is a 5-HT6 antagonist with acute cognition enhancing activities
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922928
retrieved
5 July 2018
Animal models of polyglutamine diseases and therapeutic approaches
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922928
retrieved
5 July 2018
Evaluation of Dimebon in cellular model of Huntington's disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922928
retrieved
5 July 2018
Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922928
retrieved
5 July 2018
5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922928
retrieved
5 July 2018
Comparative study of action mechanisms of dimebon and memantine on AMPA- and NMDA-subtypes glutamate receptors in rat cerebral neurons
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922928
retrieved
5 July 2018
Mitochondria as a target for neurotoxins and neuroprotective agents
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922928
retrieved
5 July 2018
Dimebon and tacrine inhibit neurotoxic action of beta-amyloid in culture and block L-type Ca(2+) channels
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922928
retrieved
5 July 2018
Antihistamine agent Dimebon as a novel neuroprotector and a cognition enhancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922928
retrieved
5 July 2018
Dimebon improves learning in animals with experimental Alzheimer's disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922928
retrieved
5 July 2018
Action of dimebon on histamine receptors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922928
retrieved
5 July 2018
Identifiers
DOI
10.1358/DNP.2010.23.8.1500435
1 reference
stated in
Europe PubMed Central
PubMed ID
21031168
retrieved
31 July 2017
PMCID
3922928
1 reference
stated in
Europe PubMed Central
PubMed ID
21031168
retrieved
31 July 2017
PubMed ID
21031168
1 reference
stated in
Europe PubMed Central
PubMed ID
21031168
retrieved
31 July 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
